Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Handbook of Acute Leukemia (eBook)

Wolfgang Hiddemann (Herausgeber)

eBook Download: PDF
2016 | 1st ed. 2016
XIV, 92 Seiten
Springer International Publishing (Verlag)
978-3-319-26772-2 (ISBN)

Lese- und Medienproben

Handbook of Acute Leukemia -
Systemvoraussetzungen
53,49 inkl. MwSt
(CHF 52,25)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
This book provides an overview of the key developments in both acute lymphocytic leukemia and acute myeloid leukemia with a comprehensive guide to the epidemiology, pathogenesis, etiology, clinical manifestations, classification, diagnosis, and staging as well as the most recent developments in the therapeutic landscape for acute leukemia. The Handbook of Acute Leukemia offers readers a key resource into the future outlook for patients with leukemia and is edited and authored by internationally renowned experts in the field. Leukemia is cancer of the white blood cells and acute leukemia means the condition progresses rapidly and aggressively, requiring immediate treatment. Acute leukemia is classified according to the type of white blood cells that are affected: either lymphocytes and myeloid cells.

Wolfgang Hiddemann, MD, PhD, is Professor of Medicine and Director of the Department of Internal Medicine III at the University of Munich,Germany. Dr Hiddemann is best known for his research on the pathogenesis of acute leukemias, and clinical trials in acute leukemias and malignant lymphomas. He is head of the German AML Cooperative Group (AMLCG), the German Low Grade Lymphoma Study Group (GLSG), and founding chairman of the European Mantle-Cell-Lymphoma Network. He is an active member of the editorial boards of several international journals and has been a member of the Steering Committees for the German Society of Hematology and Oncology and the German Cancer
Aid. Dr Hiddemann has published nearly 600 scientific articles addressing various aspects of research in malignant lymphomas and acute leukemias. He has been awarded honorary memberships of the Hungarian Society of Hematology and Oncology and of the South African Society for Hematology. He also received the Honorary Medal of the Polish Society for Internal Medicine. In 2003, he was awarded the Charles Burpbacher Lectureship in Zürich, Switzerland, and in the same year the Emil Frei Leukemia Lectureship, Harvard University, Boston. He has also received the Jacqueline Seroussi Foundation Scientific Award.

Wolfgang Hiddemann, MD, PhD, is Professor of Medicine and Director of the Department of Internal Medicine III at the University of Munich,Germany. Dr Hiddemann is best known for his research on the pathogenesis of acute leukemias, and clinical trials in acute leukemias and malignant lymphomas. He is head of the German AML Cooperative Group (AMLCG), the German Low Grade Lymphoma Study Group (GLSG), and founding chairman of the European Mantle-Cell-Lymphoma Network. He is an active member of the editorial boards of several international journals and has been a member of the Steering Committees for the German Society of Hematology and Oncology and the German CancerAid. Dr Hiddemann has published nearly 600 scientific articles addressing various aspects of research in malignant lymphomas and acute leukemias. He has been awarded honorary memberships of the Hungarian Society of Hematology and Oncology and of the South African Society for Hematology. He also received the Honorary Medal of the Polish Society for Internal Medicine. In 2003, he was awarded the Charles Burpbacher Lectureship in Zürich, Switzerland, and in the same year the Emil Frei Leukemia Lectureship, Harvard University, Boston. He has also received the Jacqueline Seroussi Foundation Scientific Award.

Introduction.- Epidemiology, pathogenesis, and etiology of acute leukemia.- Clinical manifestations and diagnosis.- Diagnostic criteria, classification, and prognosis of acute leukemia.- Therapeutic management of acute myeloid leukemia.- Therapeutic management of acute promyelocytic leukemia.- Therapeutic management of acute lymphoblastic leukemia.- Future outlook for acute leukemia

Erscheint lt. Verlag 14.11.2016
Zusatzinfo XIV, 92 p. 5 illus. in color.
Verlagsort Cham
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Allgemeinmedizin
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Schlagworte Acute Leukemia • Blood disorder • Cancer • Hematology • leukemia • Oncology
ISBN-10 3-319-26772-8 / 3319267728
ISBN-13 978-3-319-26772-2 / 9783319267722
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 1,1 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich